![](https://d3ilqtpdwi981i.cloudfront.net/e_7DYeFUKIZ-BQJznE1f7m7Tyn4=/425x550/smart/https://bepress-attached-resources.s3.amazonaws.com/uploads/0b/af/8c/0baf8c7c-8183-4a07-9e20-d27cd1164cc2/file.png)
Article
Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group
Neuro-oncology
(2019)
Disciplines
Publication Date
January 1, 2019
DOI
10.1093/NEUONC/NOY137
Citation Information
Raymond Y. Huang, Wenya Linda Bi, Michael Weller, Thomas Kaley, et al.. "Proposed response assessment and endpoints for meningioma clinical trials: report from the Response Assessment in Neuro-Oncology Working Group" Neuro-oncology Vol. 21 Iss. 1 (2019) p. 26 - 36 Available at: http://works.bepress.com/michael-mcdermott/304/